SCHOENBERG MARK (Chief Medical Officer) sold 6.7% of their position (10K shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $250.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/20/2025ACC: 0001437749-25-035821
Officer· Chief Medical Officer
Since Jan 2019
-10K
Net shares
Net seller
$250.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−10K
Price / share
$25.00
Trade value
$250K
% of position
6.7%
11/19/2025
149.03K→139.03K
Total
Net shares
−10K
Net value
-$250K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 11/19/2025 | S · Sale | −10K | $25.00 | $250K | 6.7% | 149.03K | 139.03K |
| Total | −10K | -$250K | ||||||
Derivative Transactions0
No derivative transactions reported